Literature DB >> 21987593

Promoting research in advanced dementia: early clinical results of the Alzheimer Center Reina Sofía Foundation.

Javier Olazarán1, Luis Agüera-Ortiz, Ricardo S Osorio, Beatriz León-Salas, José Luis Dobato, Isabel Cruz-Orduña, Belén González, Meritxell Valentí, Nuria Gil-Ruiz, Belén Frades, M I Ramos-García, Pablo Martínez-Martín.   

Abstract

The Alzheimer Center Reina Sofía Foundation (ACRSF) was envisaged to address the complex and multi-disciplinary research and care needs posed by Alzheimer's disease (AD) and other neurodegenerative dementias. Patients may be admitted at ACRSF either as inpatients (i.e., nursing home) or outpatients (i.e., day-care center). The research program includes clinical, social, biochemical, genetic, and magnetic resonance investigations, as well as brain donation. We present the inception of the clinical research protocol for the ACRSF, the early results, and the amendments to the protocol. Foreseen as distinct populations, inpatient and outpatient results are presented separately. Data were collected from 180 patients (153 inpatients, 27 outpatients) (86% AD), with informed consent for participation in the research program of the ACRSF. Most patients (95%) had moderate to severe dementia. Nursing home patients were older, displayed marked gait dysfunction, and were significantly more dependent in the activities of daily living (ADL), compared to the day-care patients (p < 0.05). Some cognitive, ADL, and quality of life (QoL) scales were eliminated from the protocol due to floor effect or lack of specificity of contents for advanced dementia. New measurements were added for evaluation of cognition, apathy, agitation, depression, ADL, motor function, and QoL. The final assessment is expected to be sensitive to change in all the clinical aspects of advanced degenerative dementia, to promote multidisciplinary and, desirably, inter-center collaborative research and, eventually, to contribute to the improvement of treatment and care for these patients.

Entities:  

Mesh:

Year:  2012        PMID: 21987593     DOI: 10.3233/JAD-2011-110875

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  4 in total

1.  Validation of the multimodal assessment of capacities in severe dementia: a novel cognitive and functional scale for use in severe dementia.

Authors:  Sloane Heller; Carolina Mendoza Rebolledo; Carmen Rodríguez Blázquez; Laura Carrasco Chillón; Almudena Pérez Muñoz; Irene Rodríguez Pérez; Pablo Martínez-Martín
Journal:  J Neurol       Date:  2015-03-06       Impact factor: 4.849

2.  Processes of consent in research for adults with impaired mental capacity nearing the end of life: systematic review and transparent expert consultation (MORECare_Capacity statement).

Authors:  C J Evans; E Yorganci; P Lewis; J Koffman; K Stone; I Tunnard; B Wee; W Bernal; M Hotopf; I J Higginson
Journal:  BMC Med       Date:  2020-07-22       Impact factor: 8.775

3.  Social robots in advanced dementia.

Authors:  Meritxell Valentí Soler; Luis Agüera-Ortiz; Javier Olazarán Rodríguez; Carolina Mendoza Rebolledo; Almudena Pérez Muñoz; Irene Rodríguez Pérez; Emma Osa Ruiz; Ana Barrios Sánchez; Vanesa Herrero Cano; Laura Carrasco Chillón; Silvia Felipe Ruiz; Jorge López Alvarez; Beatriz León Salas; José M Cañas Plaza; Francisco Martín Rico; Gonzalo Abella Dago; Pablo Martínez Martín
Journal:  Front Aging Neurosci       Date:  2015-09-03       Impact factor: 5.750

4.  Validation of the English Version of the Multimodal Assessment of Capacities in Severe Dementia (MAC-SD): A Cognitive and Functional Scale for Use in Severe Dementia.

Authors:  Sloane Heller; Alan Steinberg; Mark Sedler
Journal:  J Alzheimers Dis Rep       Date:  2017-12-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.